PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Christopher Weil & Company, Inc.

Press Release


Receive press releases from Christopher Weil & Company, Inc.: By Email RSS Feeds:

Christopher Weil & Company Venture Fund Investment Reaches Major Milestone


Boston Scientific announces a definitive agreement to acquire Vessix Vascular, Inc.

San Diego, CA, November 10, 2012 --(PR.com)-- Christopher Weil & Company, Inc. (CWC), a financial services firm that services clients nationwide, today announced that its private equity fund, CWC MedDev LLC, which provided early financing for Vessix Vascular, Inc., will be acquired by Boston Scientific by the end of this month.
http://bostonscientific.mediaroom.com/2012-11-08-Boston-Scientific-to-Acquire-Vessix-Vascular-Inc.

“It was exciting to help a company like Vessix Vascular get off the ground,” said John Wells, CWC CEO. “The technology they have developed will provide essential treatment of uncontrolled hypertension. And with hypertension as the leading attributable cause of death worldwide, I believe it was money well invested and share the confidence of Vessix CEO, Raymond Cohen, that joining forces with Boston Scientific will result in a new standard of treatment.”

Christopher Weil & Company, Inc., together with affiliates, has sponsored and managed over fifty private equity funds formed to invest in real estate, oil/gas operations, small business equity, venture capital and specialty securities portfolios.

About Vessix Vascular
Founded in 2003, Vessix is a private company developing novel RF balloon catheter and bipolar RF generator technology. The company has operations in the United States and in Europe, and is backed by world-class European and U.S. venture capital firms including NeoMed Management, Edmond de Rothschild Investment Partners, OrbiMed Advisors LLC and Christopher Weil & Company. Matthew Weil, CWC Managing Director, has been named to the Shareholder Committee of Vessix Vascular, to help assure a smooth transition for shareholders involved in this acquisition.

About Boston Scientific
Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/.

About Christopher Weil & Company
Christopher Weil & Company, Inc. ("CWC") is a San Diego-based financial services firm that services clients nationwide. With over forty years in the financial world, CWC, together with its affiliates, work from every angle as investors, managers and advisors to bring their clients peace of mind. The firm is both a securities broker-dealer and a registered investment advisor, enabling it to provide a comprehensive and integrated mix of client services. CWC is innovative in responding to client needs and dedicated to nimble, intelligent customer service with a personal, family touch. For more information, please visit www.cweil.com.
Contact Information
Christopher Weil & Company, Inc.
Sandra Korwek
800-355-WEIL
Contact
www.cweil.com
Media contact: Cynthia Guiang
CG Communications
858-793-2471

Click here to view the list of recent Press Releases from Christopher Weil & Company, Inc.
Promote Your Business